Immuron IMRN
NASDAQ IMRN
$1.19 +0.03 (+2.59%)
At close: Sep 29, 2026 · 4:00 PM EDT

Immuron (IMRN) Operating Leases (2019 - 2026)

Updated

Immuron's Operating Leases was $30,606 in fiscal Q4 2026 (quarter ended Aug 28, 2026).

Analysis

Immuron (IMRN) Operating Leases (2019 - 2026) Analysis & Trends

From fiscal Q4 2019 onward, Immuron has reported Operating Leases for 4 quarters.

  • Operating Leases shows a four-year compound annual growth rate of -30.0% (FY2022 to FY2026).
  • In earlier fiscal years, Operating Leases was $45,272 in FY2025 and $127,342 in FY2022.
  • The fiscal Q4 2026 figure marks the highest quarterly Operating Leases since fiscal Q4 2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn
10 Immuron 9.36 Mn -7.94 Mn -
Historic Data

Historic Data

Download Data
DateValue
Aug 28, 2026 30,606.00
Jun 30, 2022 125,641.34
Jun 30, 2020 12,406.46
Dec 31, 2019 61,105.00
Jun 30, 2019 10,493.07
API Access

Immuron Operating Leases API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-leases&ticker=IMRN&period=max&api_key=YOUR_API_KEY